Showing results (181-190 of 201) with videos related to

Sort By:
Pageof 21
Cancer Research|August 15, 2008
Loss of the CBX7 gene expression correlates with a highly malignant phenotype in thyroid cancerPierlorenzo Pallante, Antonella Federico, Maria Teresa Berlingieri, et al.
Molecular Cell|June 10, 2014
NCOA4 transcriptional coactivator inhibits activation of DNA replication originsRoberto Bellelli, Maria Domenica Castellone, Teresa Guida, et al.
Oncogene|June 9, 2004
Functional expression of the CXCR4 chemokine receptor is induced by RET/PTC oncogenes and is a common event in human papillary thyroid carcinomasMaria D Castellone, Valentina Guarino, Valentina De Falco, et al.
Cancer Letters|May 18, 2004
Low prevalence of BRAF mutations in radiation-induced thyroid tumors in contrast to sporadic papillary carcinomasMarina N Nikiforova, Raffaele Ciampi, Giuliana Salvatore, et al.
European Journal of Medicinal Chemistry|May 21, 2025
Discovery of N-(3-fluorophenyl)-2-(4-((7-(1-methyl-1H-pyrazol-4-yl)quinazolin-4-yl)amino)phenyl)acetamide as the first orally active selective aurora kinase B inhibitorPhuc Tran, Marialuisa Moccia, Xiuqi Wang, et al.
Endocrine-Related Cancer|June 26, 2010
Extracellular superoxide dismutase is a thyroid differentiation marker down-regulated in cancerLilja E Laatikainen, Maria D Castellone, Aline Hebrant, et al.
The Journal of Clinical Endocrinology and Metabolism|November 7, 2003
BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomasMarina N Nikiforova, Edna T Kimura, Manoj Gandhi, et al.
Oncogene|June 26, 2002
Overexpression of the HMGA2 gene in transgenic mice leads to the onset of pituitary adenomasMonica Fedele, Sabrina Battista, Lawrence Kenyon, et al.
Cancer Research|July 20, 2007
The RET kinase inhibitor NVP-AST487 blocks growth and calcitonin gene expression through distinct mechanisms in medullary thyroid cancer cellsNagako Akeno-Stuart, Michelle Croyle, Jeffrey A Knauf, et al.
Endocrine-Related Cancer|August 25, 2012
FOXM1 is a molecular determinant of the mitogenic and invasive phenotype of anaplastic thyroid carcinomaRoberto Bellelli, Maria Domenica Castellone, Ginesa Garcia-Rostan, et al.
Pageof 21